ChemicalBook > CAS DataBase List > Pirprofen

Pirprofen

Product Name
Pirprofen
CAS No.
31793-07-4
Chemical Name
Pirprofen
Synonyms
Su-21524;Pirprofen;Pirprofen USP/EP/BP;PIDSZXPFGCURGN-UHFFFAOYSA-N;3-Chloro-4-(3-pyrrolin-1-yl)hydratropic acid;2-[3-Chloro-4-(3-pyrrolin-1-yl)phenyl]propanoic acid;2-[3-Chloro-4-(2,5-dihydro-1H-pyrrol-1-yl)phenyl]propionic acid;2-[3-Chloro-4-(2,5-dihydro-1H-pyrrole-1-yl)phenyl]propanoic acid;Benzeneacetic acid, 3-chloro-4-(2,5-dihydro-1H-pyrrol-1-yl)-α-methyl-
CBNumber
CB2875239
Molecular Formula
C13H14ClNO2
Formula Weight
251.71
MOL File
31793-07-4.mol
More
Less

Pirprofen Property

Melting point:
98-100°
Boiling point:
410.8±45.0 °C(Predicted)
Density 
1.1778 (rough estimate)
refractive index 
1.5270 (estimate)
storage temp. 
-20°C Freezer, Under inert atmosphere
solubility 
DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
form 
Solid
pka
4.56±0.10(Predicted)
color 
Off-White
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Usbiological
Product number
462709
Product name
Pirprofen
Packaging
25mg
Price
$460
Updated
2021/12/16
TRC
Product number
P510600
Product name
Pirprofen
Packaging
250mg
Price
$1455
Updated
2021/12/16
Medical Isotopes, Inc.
Product number
61328
Product name
Pirprofen
Packaging
250mg
Price
$2200
Updated
2021/12/16
American Custom Chemicals Corporation
Product number
API0012288
Product name
PIRPROFEN
Purity
95.00%
Packaging
5MG
Price
$496.73
Updated
2021/12/16
More
Less

Pirprofen Chemical Properties,Usage,Production

Originator

Rengasil, Ciba Geigy ,France ,1981

Uses

Pirprofen is a non-steroidal anti-inflammatory drug.

Uses

Anti-inflammatory.

Definition

ChEBI: Pirprofen is a pyrroline.

Manufacturing Process

To the mixture of 85.5 g ethyl α-(3-chloro-4-aminophenyl)-propionate hydrochloride, 142 g sodium carbonate and 600 ml dimethyl formamide, 107g 1,4-dibromo-2-butene are added dropwise while stirring and the whole is refluxed for 5 hours and allowed to stand overnight at room temperature. The mixture is filtered, the filtrate evaporated in vacuo, the residue is triturated with hexane, the mixture filtered, the residue washed with petroleum ether and the filtrate evaporated. The residue is combined with 280 ml 25% aqueous sodium hydroxide and the mixture refluxed for 8 hours. After cooling, it is diluted with water, washed with diethyl ether, the pH adjusted to 5 to 5.2 with hydrochloric acid and extracted with diethyl ether. The extract is dried, filtered, evaporated and the residue crystallized from benzene-hexane, to yield the α-(3-chloro-4-pyrrolinophenyl)-propionic acid melting at 94°C to 96°C.

Therapeutic Function

Antiinflammatory

World Health Organization (WHO)

Pirprofen, a nonsteroidal anti-inflammatory agent, was introduced in 1982 primarily for the treatment of rheumatic diseases, as well as for use in posttraumatic and post-operative inflammatory conditions, acute gout and dysmenorrhoea. Reports of serious adverse effects, in particular cases of liver toxicity, some of which were fatal, led the manufacturer, in 1985 and in 1989, to amend the approved product information of the drug, limiting duration of treatment and lowering the recommended doses. In the light of these successive restrictions, which have considerably reduced the field of application of pirprofen and in view of available alternatives, the manufacturer has decided to discontinue the drug worldwide.

Trade name

Rengasil (Ciba, Greece), Seflenyl (Geigy, Argentina).

Clinical Use

Pirprofen has been used to treat rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. An optimal dosing regimen of 200 mg three times a day has been developed for maximal activity with minimal adverse effects. Pirprofen also is effective in relieving pain from malignant disease and oral surgery.

Synthesis

Synthesis: treatment of the sodium salt of diethyl methylmalonate with 2,4- dichloronitrobenzene yields diethyl (3-chloro- 4-nitrophenyl)methylmalonate. Saponification, decarboxylation, and subsequent reesterification followed by catalytic reduction gives ethyl 4-amino-3-chloro-α-methylbenzeneacetate hydrochloride. Treatment of the latter with 1,4- dichloro-2-butene in the presence of sodium carbonate followed by saponification affords pirprofen.

Pirprofen Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Pirprofen Suppliers

Dideu Industries Group Limited
Tel
+86-29-89586680 +86-15129568250
Email
1026@dideu.com
Country
China
ProdList
29016
Advantage
58
Wuhan pengyin Pharmaceutical Co., Ltd
Tel
13163333255
Email
1939328613@qq.com
Country
China
ProdList
395
Advantage
58
Energy Chemical
Tel
021-58432009 400-005-6266
Fax
021-58436166
Email
marketing@energy-chemical.com
Country
China
ProdList
44941
Advantage
58
Baoji Didu Pharmaceutical and Chemical Co., Ltd
Tel
029-61856358 15829046862
Email
1035@dideu.com
Country
China
ProdList
10011
Advantage
58
Shanghai Aladdin Biochemical Technology Co.,Ltd.
Tel
+86-18521732826
Email
market@aladdin-e.com
Country
China
ProdList
48570
Advantage
58
Aladdin Scientific
Tel
+1-833-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
57511
Advantage
58
More
Less

View Lastest Price from Pirprofen manufacturers

Dideu Industries Group Limited
Product
Pirprofen 31793-07-4
Price
US $1.10/g
Min. Order
1g
Purity
99.9%
Supply Ability
100 Tons Min
Release date
2021-06-15

31793-07-4, PirprofenRelated Search:


  • Pirprofen
  • 2-[3-Chloro-4-(2,5-dihydro-1H-pyrrol-1-yl)phenyl]propionic acid
  • 2-[3-Chloro-4-(2,5-dihydro-1H-pyrrole-1-yl)phenyl]propanoic acid
  • 2-[3-Chloro-4-(3-pyrrolin-1-yl)phenyl]propanoic acid
  • 3-Chloro-4-(3-pyrrolin-1-yl)hydratropic acid
  • Su-21524
  • PIDSZXPFGCURGN-UHFFFAOYSA-N
  • Benzeneacetic acid, 3-chloro-4-(2,5-dihydro-1H-pyrrol-1-yl)-α-methyl-
  • Pirprofen USP/EP/BP
  • 31793-07-4